Enhancing hepatitis C testing and treatment among people who inject drugs attending needle and syringe programs: the TEMPO Study [ 2019 - ]

Research Grant

Brief description In Australia, 170,000 people are living with hepatitis C, with the majority having a history of injecting drug use (80%) or recent injecting drug use (20%). Reducing the hepatitis C burden requires enhanced hepatitis C testing and treatment for people who inject drugs. This Partnership Project will evaluate an intervention to enhance hepatitis C testing and treatment in needle and syringe programs and develop a translational framework for establishing hepatitis C care in this setting nationally.

Funding Amount $1,396,395.00

Funding Scheme Partnerships

Notes Partnership Project for Better Health